PHASE II TRIAL OF LENALIDOMIDE, DEXAMETHASONE AND CYCLOPHOSPHAMIDE (LENDEXAL) FOR PREVIOUSLY UNTREATED PATIENTS WITH LIGHT-CHAIN AMYLOIDOSISM. T. Cibeira,A. Oriol, J. J. Lahuerta,M. V. Mateos,J. de la Rubia,M. Hernandez,M. Granell,C. Fernandez de Larrea,J. F. San Miguel,J. BladeHAEMATOLOGICA(2014)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要